Abstract
Background
Patients can experience barriers and disparities to access high-quality cancer care. This study sought to characterize receipt of surgery and chemotherapy among Medicare beneficiaries with a diagnosis of early-stage pancreatic adenocarcinoma cancer (PDAC) relative to race/ethnicity and social vulnerability.
Methods
The Surveillance, Epidemiology, and End Results (SEER)-Medicare database was used to identify patients with a diagnosis of early-stage (stage 1 or 2) PDAC between 2004 and 2016. Data were merged with the CDC’s Social Vulnerability Index (SVI) at the beneficiary’s county of residence. Multivariable, mixed-effects logistic regression was used to assess the association of SVI with resection.
Results
Among 15,931 older Medicare beneficiaries with early-stage PDAC (median age, 77 years; interquartile range [IQR], 71–82 years), the majority was White (n = 12,737, 80.0 %), whereas a smaller subset was Black or Latino (n = 3194, 20.0 %) A minority of patients was more likely to live in highly vulnerable communities (low SVI: white [90.5 %] vs minority [9.5 %] vs high SVI: white [71.9 %] vs minority [28.1 %]; p < 0.001). Use of resection for early-stage PDAC was lowest among the patients who resided in high-SVI areas (low [38.0 %] vs average [34.3 %] vs high [31.9 %]; p < 0.001). The minority patients were less likely to undergo resection than the White patients (no resection: white [64.1 %] vs minority [70.7 %]; p < 0.001). The median SVI was higher among the patients who underwent resection (57.6; IQR, 36.0–81.0) than among those who did not (60.4; IQR, 41.9–84.3), and increased SVI resulted in a decline in the likelihood of resection (SVI trend: OR, 0.98; 95 % confidence interval [CI], 0.97–1.00), especially among the minority patients. Minority patients from high-SVI counties had markedly lower odds of preoperative chemotherapy than minority patients from a low-SVI neighborhood (OR, 0.62; 95 % CI, 0.52–0.73).
Conclusions
Older Medicare beneficiaries with early-stage PDAC residing in counties with higher social vulnerability had lower odds of undergoing pancreatic resection, which was more pronounced among minority versus older White Medicare beneficiaries.
Similar content being viewed by others
References
Burgess DJ, Fu SS, van Ryn M. Why do providers contribute to disparities and what can be done about it? J Gen Intern Med. 2004;19:1154–9.
Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc. 2002;94(8):666–8.
Wallen J, Waitzkin H, Stoeckle J. Physician stereotypes about female health and illness: a study of patient’s sex and the informative process during medical interviews. Women Health. 1979;4:135–46.
Adler NE, Newman K. Socioeconomic disparities in health: pathways and policies. Health Aff Millwood. 2002;21:60–76.
Diaz A, Chavarin D, Paredes AZ, et al. Association of neighborhood characteristics with utilization of high-volume hospitals among patients undergoing high-risk cancer surgery. Ann Surg Oncol. 2020;28(2):617–31. https://doi.org/10.1245/s10434-020-08860-5.
Buchmueller TC, Levinson ZM, Levy HG, et al. Effect of the Affordable Care Act on racial and ethnic disparities in health insurance coverage. Am J Public Health. 2016;106:1416–21.
Azap RA, Paredes AZ, Diaz A, et al. The association of neighborhood social vulnerability with surgical textbook outcomes among patients undergoing hepatopancreatic surgery. Surgery. 2020;168(5):868–875. https://doi.org/10.1016/j.surg.2020.06.032.
Braveman PA, Cubbin C, Egerter S, et al. Socioeconomic disparities in health in the United States: what the patterns tell us. Am J Public Health. 2010;100(Suppl 1):S186–96.
Diaz A, Hyer JM, Barmash E, et al. County-level social vulnerability is associated with worse surgical outcomes especially among minority patients. Ann Surg. 2020. https://doi.org/10.1097/SLA.0000000000004691.
Frist WH. Overcoming disparities in U.S. health care. Health Aff Millwood. 2005;24:445–51.
Shavers VL. Racial and ethnic disparities in the receipt of cancer treatment. CancerSpectrum Knowl Environ. 2002;94:334–57.
Basu A, Ghosh D, Mandal B, et al. Barriers and explanatory mechanisms in diagnostic delay in four cancers: a health-care disparity? South Asian J Cancer. 2019;8:221–5.
Gamboa AC, Rupji M, Switchenko JM, et al. Optimal timing and treatment strategy for pancreatic cancer. J Surg Oncol. 2020;122:457–68.
Vick AD, Hery DN, Markowiak SF, et al. Closing the disparity in pancreatic cancer outcomes: a closer look at nonmodifiable factors and their potential use in treatment. Pancreas. 2019;48:242–9.
Gold JS. Linking disparities to outcomes in pancreatic cancer: inching toward answers. JAMA Surg. 2020;155:e195082.
Scarton L, Yoon S, Oh S, et al. Pancreatic cancer-related health disparities: a commentary. Cancers. 2018;10(7):235. https://doi.org/10.3390/cancers10070235.
Tavakkoli A, Singal AG, Waljee AK, et al. Racial disparities and trends in pancreatic cancer incidence and mortality in the United States. Clin Gastroenterol Hepatol. 2020;18(171–178):e10.
Heller DR, Nicolson NG, Ahuja N, et al. Association of treatment inequity and ancestry with pancreatic ductal adenocarcinoma survival. JAMA Surg. 2020;155:e195047.
Noel M, Fiscella K. Disparities in pancreatic cancer treatment and outcomes. Health Equity. 2019;3:532–40.
Khawja SN, Mohammed S, Silberfein EJ, et al. Pancreatic cancer disparities in African Americans. Pancreas. 2015;44:522–7.
Nipp R, Tramontano AC, Kong CY, et al. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer. Cancer Med. 2018;7:525–35.
CDC’s Social Vulnerability Index. 2018. Retrieved 14 March 2020 at https://svi.cdc.gov/.
Bilimoria KY, Bentrem DJ, Ko CY, et al. Validation of the 6th-edition AJCC pancreatic cancer staging system. Cancer. 2007;110:738–44.
AJCC. Understanding the changes from the sixth to the seventh edition of the AJCC Cancer Staging Manual. Retrieved 3 March 2021 at https://cancerstaging.org/references-tools/deskreferences/Documents/AJCCSummaryofChanges.pdf.
Quan H, Li B, Couris CM, et al. Updating and validating the Charlson Comorbidity Index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–82.
Agency for Toxic Substances and Disease Registry. CDC’s Social Vulnerability Index (SVI). https://svi.cdc.gov/factsheet.html. Accessed 15 Nov 2020.
Social Determinants of Health/Healthy People 2020. Retrieved 7 September 2020 at https://www.healthypeople.gov/2020/topics-objectives/topic/social-determinants-of-health.
Social Determinants of Health–Healthy People 2030/health.gov. Retrieved 23 December 2020 at https://health.gov/healthypeople/objectives-and-data/social-determinants-health.
Diaz A, Chavarin D, Paredes AZ, et al. Association of neighborhood characteristics with utilization of high-volume hospitals among patients undergoing high-risk cancer surgery. Ann Surg Oncol. 2021;28(2):617–31. https://doi.org/10.1245/s10434-020-08860-5.
Hyer JM, Tsilimigras DI, Diaz A, et al. High social vulnerability and “textbook outcomes” after cancer surgery. J Am Coll Surg. 2021;232(4):351–9. https://doi.org/10.1016/j.jamcollsurg.2020.11.024.
Xu L, Kim Y, Spolverato G, et al. Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States. Hepatobiliary Surg Nutr. 2016;5:43–52.
Nathan H, Frederick W, Choti MA, et al. Racial disparity in surgical mortality after major hepatectomy. J Am Coll Surg. 2008;207:312–9.
Khubchandani JA, Shen C, Ayturk D, et al. Disparities in access to emergency general surgery care in the United States. Surgery. 2018;163:243–50.
Racial Disparities in Total Knee Replacement Among Medicare Enrollees: United States, 2000–2006. 25 June 2020 at https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5806a1.htm.Retrieved.
Chen JT, Rehkopf DH, Waterman PD, et al. Mapping and measuring social disparities in premature mortality: the impact of census tract poverty within and across Boston neighborhoods, 1999–2001. J Urban Health Bull N Y Acad Med. 2006;83:1063–84.
Azap RA, Hyer JM, Diaz A, et al. Association of county-level vulnerability, patient-level race/ethnicity, and receipt of surgery for early-stage Hepatocellular Carcinoma. JAMA Surg. 2021;156(2):197–9. https://doi.org/10.1001/jamasurg.2020.5554.
Boyd RW, Lindo EG, Weeks LD, et al. On racism: a new standard for publishing on racial health inequities/Health Affairs Blog. Retrieved 20 November 2020 at /do/https://doi.org/10.1377/hblog20200630.939347/full.
Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995;Spec No:80–94.
Phelan JC, Link BG. Is racism a fundamental cause of inequalities in health? Annu Rev Sociol. 2015;41:311–30.
Lucyk K, McLaren L. Taking stock of the social determinants of health: a scoping review. Plos One. 2017;12:e0177306.
Taylor LA, Tan AX, Coyle CE, et al. Leveraging the social determinants of health: what Works? Plos One. 2016;11:e0160217.
Acknowledgments
Adrian Diaz receives funding from the University of Michigan Institute for Healthcare Policy and Innovation Clinician Scholars Program and received salary support from the Veterans Affairs Office of Academic Affiliations during this study. The remaining authors have no conflicts of interest. The views expressed in this article are not necessarily represent those of the United States Government or the Department of Veterans Affairs.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Azap, R.A., Diaz, A., Hyer, J.M. et al. Impact of Race/Ethnicity and County-Level Vulnerability on Receipt of Surgery Among Older Medicare Beneficiaries With the Diagnosis of Early Pancreatic Cancer. Ann Surg Oncol 28, 6309–6316 (2021). https://doi.org/10.1245/s10434-021-09911-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-09911-1